INTRODUCTION
Esophageal adenocarcinoma has the highest incidence in UK, globally at up to 8.7 cases /100,000 of the population 1 with Caucasian male being the most commonly affected ethnic group. 2 Despite modern therapies, overall 5years survival is less than 25%. 3 In an attempt to harmonize staging the latest AJCC/UICC included carcinoma of gastro esophageal junction with carcinoma of esophagus. This includes tumor arising from the distal 5cm of the esophagus, the GEJ or cardia of the stomach within 5cm of the GEJ. 4 Carcinoma esophagus (adenocarcinoma) is presented either as a result of denovo or after Barrette's esophagus and cause progressive dysphagia from solid to liquid and weight loss. Esophageal adenocarcinoma presents late as symptoms only manifest when tumors become large enough to cause dysphagia or pain. Unfortunately the majority of esophageal adenocarcinoma has invaded through the esophageal wall at the time of diagnosis. 7 Surgery remains the main stay of the treatment for resectable diseases but most patients in western countries present with locally advanced disease and 5 year survival rate with surgery alone are dismal at approximately 25%. 8 Outcomes for esophageal adenocarcinoma are poor because 60-70% of patients present with late stage disease, too advanced for treatment with curative intent. 9 This is partly due to the mechanically compliant esophageal anatomy which allow symptomless tumor expansion. 10 Additionally tumor invasion and metastases are facilitated by the absence of outer serosal layer and the presence of rich lymphatic plexus and both depth and nodal metastases are prognostic.
11
In an attempt to improve outcome multimodal strategies have been investigated with variable results. The optimal management remains controversial and practices vary across the world. 12 Carcinoma of stomach is the third leading cause of cancer related death and fifth most common malignancy worldwide. 13 Malignant gastric outlet obstruction is commonly reported in 20% cases.
14 It implies complete or incomplete obstruction of distal stomach, pylorus or proximal duodenum.
Traditionally malignant gastric outlet obstruction has been surgically treated by gastrojejunostomy (GJ). 15 It is a less invasive surgery than gastrectomy & might nonetheless cause substantial trauma in patients with malignant GOO. 13 In contrast an advanced approach is necessary for the treatment of advanced gastric cancer. Total gastrectomy with the exception of distal tumor that can be treated by subtotal gastrectomy is the procedure of choice. 16 The prognosis after surgical treatment remains poor. Potential values of neo adjuvant or adjuvant chemotherapy in gastric cancer studied in randomized controlled trials are still scarce and it remains uncertain which subgroup of patients should routinely undergo multimodal treatment. 17 The need of adjuvant treatment is obvious but at present there is no such treatment of proven effectiveness. Promising results with preoperative chemotherapy which increases the Ro resection rate and intra or early postoperative intra peritoneal chemo hyperthermia to prevent peritoneal dissemination have been reported. 18 Aim of my study is to know the frequency of gastroesophageal carcinoma and its management at Isra University Hospital Hyderabad Sindh.
MATERIAL AND METHODS

Study Design
Descriptive, Prospective study.
Place and Duration of Study
Isra University Hospital Hyderabad during the period of January 2014 to January2016.
Patient and Methods
In Surgical Unit II at Isra University Hospital Hyderabad around fifty two (52) patients were admitted through OPD and emergency room. They all were scrutinized for elective or emergency surgery if needed. All patient's bio data, clinical presentation, staging, operative procedure and post-operative complications were recorded in the preset approved Performa. Data is prepared in SPSS version 17.
Inclusion Criteria
Carcinoma of esophagus and stomach. Major presenting complaints of carcinoma of esophagus were progressive dysphagia from solid to liquid with significant weight loss while history of heamatemesis was found in only two patients. Carcinoma stomach mainly presented with symptoms of gastric outlet obstruction (GOO); partial or complete I.e. vomiting, fullness and epigastric mass with weight loss. Out of total 52 patients; 35 were biopsied and staged preoperatively while 17 patients could not be biopsied before surgery either because of inadequate tissue specimen or scope negotiation problem. However after surgery their biopsy was found out malignant. All such patients were optimized before surgery for correction of hemoglobin, electrolyte imbalance and nutritional support.
Exclusion Criteria
Age wise predilection of carcinoma esophagus and stomach are shown in Table- Palliative surgical procedures like feeding Jejunostomy and gastrojejunostomy (GJ) for carcinoma esophagus and stomach respectively were mainly performed while for resectable tumors Ivor Lewis, McKeon or Billroth I or II were also performed according to the general patient condition and the local resectability of the tumor mass.
Stage wise procedures are highlighted in Table  II & III. After discharge all patients were sent oncology unit for adjuvant chemo radiotherapy. Our post-operative complication rate was 26% and comprised nausea, vomiting, wound infection, and delayed gastric emptying which were treated conservatively shown in Table: IV. Our operative mortality was none. Contrary to our study which accounted 46%of gastrojejunostomy, study in Tanzania showed 61%of GJ procedures for unresectable gastric carcinoma. 22 Conventional GJ adequately relieves obstructive symptoms however incidence of delayed gastric emptying after surgery was significant20-59% in other studies 23 but to us only 42.8% patient developed this complication.
Post-operative mortality after malignant gastric surgery varies from 18-24 %and after malignant esophageal surgery reported 5% 24, 23 while in our study no such operative mortality was seen in both cases.
Limitations in this study were the self-discharge & poor follow up visits of the patients, which were needed to be addressed specifically. As high frequency of gastroesophageal carcinoma seen in such remote area residents with comparatively lower socioeconomic status. And due to poverty they couldn't seek thorough early & complete treatment. 
CONCLUSION
